[Drug-drug interactions you should know!]

Area of Science:

• Pharmacology
• Clinical Medicine
• Drug Safety

Background:

• Polypharmacy and multi-morbidity are increasing, leading to a rise in potential drug-drug interactions (DDIs).
• The complexity of DDIs, including pharmacodynamic and pharmacokinetic types, poses a significant challenge in patient care.
• Unmanaged DDIs contribute to adverse drug events, increasing morbidity and mortality.

Purpose of the Study:

• To review pharmacodynamic and pharmacokinetic drug-drug interactions.
• To provide clinically relevant examples of DDIs.
• To offer practical tools for clinicians to identify and prevent DDIs.

Main Methods:

• Comprehensive literature review of pharmacodynamic DDIs.
• Extensive review of pharmacokinetic DDIs, focusing on cytochrome P450 and p-glycoproteins.
• Compilation of practical tools for clinical DDI management.

Main Results:

• Detailed overview of pharmacodynamic DDIs with examples.
• In-depth analysis of pharmacokinetic DDIs affecting drug plasma concentrations.
• Presentation of actionable strategies and tools for DDI prevention.

Conclusions:

• Increased awareness and prevention of DDIs are crucial, especially in aging populations with polypharmacy.
• Effective DDI management can significantly reduce patient mortality and morbidity.
• The provided tools aim to support clinicians in daily practice for safer medication management.